scDrug+: predicting drug-responses using single-cell transcriptomics and molecular structure - 23/07/24
, Hsueh-Fen Juan a, b, d, e, f, ⁎ 
Abstract |
Predicting drug responses based on individual transcriptomic profiles holds promise for refining prognosis and advancing precision medicine. Although many studies have endeavored to predict the responses of known drugs to novel transcriptomic profiles, research into predicting responses for newly discovered drugs remains sparse. In this study, we introduce scDrug+, a comprehensive pipeline that seamlessly integrates single-cell analysis with drug-response prediction. Importantly, scDrug+ is equipped to predict the response of new drugs by analyzing their molecular structures. The open-source tool is available as a Docker container, ensuring ease of deployment and reproducibility. It can be accessed at scDrugplus.
Il testo completo di questo articolo è disponibile in PDF.Highlights |
• | scDrug+ integrates single-cell analysis with drug-response prediction. |
• | scDrug+ predicts responses of novel drugs on cell subpopulations. |
• | Matrix factorization and SVM with molecular fingerprints show superior performance. |
Keywords : Drug-responses, Single-cell transcriptomics, Machine learning, Precision medicine
Mappa
Vol 177
Articolo 117070- agosto 2024 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
